Dr Marius Trøseid

The SolidAct project’s baricitinib trial has been featured in the Norwegian press this weekend. In the article, Principle Investigator Marius Trøseid talks about the trial, the history of the SolidAct project and, most importantly, about the need for a coordinated, pan-European trial platform to help bring new therapies to patients more quickly than in the past.

You can access the article here in the original Norwegian, or in English through Google translate at this link.

Featured Covid particle image courtesy of the CDC.